Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
Auto Finance Veteran and Former Tesla National Lease Partner Launches AmeriTrust Financial to Fill Used-Car Leasing Gap
Tartisan Nickel Corp. Intersects 10.7 Metres of 1.58% Ni, 0.79% Cu Including 5.0 Metres of 3.02% Ni, 1.48% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario
Nextech3D.ai's Krafty Lab Signs New Multinational "Tier 1" Enterprise Agreement and Expands Global In-Person Enterprise Event Delivery
Cartier Discovers Multiple Shallow High-Grade Gold Zones at Cadillac; Cuts 54.6 g/t Au over 1.0 m and 4.4 g/t Au over 6.0 m; Extends North Contact Zone 500 Meters East on Strike
